UAE launches National Genome Strategy

UAE launches National Genome Strategy

 

The UAE has unveiled its National Genome Strategy, a comprehensive initiative overseen by the Emirates Genome Council. This strategic framework involves collaboration with key stakeholders, including the Ministry of Health and Prevention, Emirates Health Services Establishment, and academic institutions like Khalifa University and NYU Abu Dhabi.

Over the next decade, the strategy aims to revolutionize the healthcare sector by focusing on preventive medicine programs targeting genetic risk and precision medicine initiatives addressing genetic and rare diseases. The anticipated outcomes include a reduction in disease prevalence, early intervention, and identification of optimal treatments, ultimately leading to cost savings in the health sector.

Beyond its impact on public health, the National Genome Strategy is expected to create economic opportunities in the UAE. By attracting partnerships in artificial intelligence, advanced medical care, pharmaceuticals, and research and technology, it aims to position the country at the forefront of innovation. Additionally, the initiative is set to foster the development of specialized local talent, generating jobs and opportunities in emerging industries.